South America and Mexico's cell and gene therapy landscape: accelerating growth and persistent challenges.
South America and Mexico are developing reliable cell and gene therapy supply chains, positioning themselves as emerging contributors to global innovation.
Cell and gene therapies (CGTs) are expanding globally, and South America and Mexico are gaining tangible momentum through rising clinical trial activity, patent filings, and industry-driven sponsorship. By reducing cell collection time, lowering costs, and converting pilot programs into reliable clinical supply chains, these regions are positioning themselves as growing contributors to global innovation in gene and cell therapy development.
What the study was
- Study design
- Literature review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Cytotherapy
Why it surfaced
Matched topic(s): Rare diseases with high unmet need. Study design: Literature review. Score 6/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.